Abstract: The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of central nervous system disorders.

Abstract: The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of central nervous system disorders.

Abstract: The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of visual system disorders and the enhancement of the visual function.

Abstract: A voltage rectifier rectifies an alternating current voltage to a direct current voltage. The voltage rectifier includes an input port for receiving the alternating current voltage; an output port for outputting the direct current voltage; a lightning protection unit; a rectifying unit; a filtering unit; a first fuse; and a second fuse. The input port, the lightning protection unit, the rectifying unit, the filtering unit, the output port are connected in series. The first fuse is connected between the input port and the lightning protection unit; the second fuse is connected between the lightning protection unit and the rectifying unit or the second fuse is connected between the rectifying unit and the filtering unit.

Abstract: A method of conducting a lawful intercept of real time media packet traffic involves redirecting real time media packet streams between a caller and callee through a media server; replicating the media packet streams within the media server; modifying packet headers of the replicated packet streams; and directing the modified packet streams to at least one monitoring port.

Abstract: In Voice-over-IP or like systems, audio mixers are used for implanting conferencing applications for IP networks. In such systems, a problem exists as how to pass through user signal events, such a DTMF digits, in-band as well as out-of-band telephony events (RFC 2833/4733) because they are not handled well in such systems. In accordance with certain embodiments, a signalling event in incoming audio packets or user signalling event received out-of-band is detected at one of the inputs. A meta-data representation of the signal event is attached to the audio and passed through the mixer for regeneration, as in-band or out-of-band telephony events, on the other side of the mixer.

Abstract: Systems and methods are provided for a distributed conferencing service through an internet protocol (IP) network. A plurality of tributary mixers are configured communicate with a master mixer or a plurality of master mixers, at least one of which communicates through the IP network. Each tributary mixer is configured to join one or more respective participants to the distributed conference, generate a first mixed media stream by mixing a plurality of ingress media streams from the respective participants, and receive a second mixed media stream from the master mixer. The second mixed media stream includes media from at least one other participant joined to the distributed conference through another of the tributary mixers. Each tributary mixer also provides egress media streams to its respective participants based on a control signal from the master mixer.

Abstract: In Voice-over-IP or like systems, audio mixers are used for implanting conferencing applications for IP networks. In such systems, a problem exists as how to pass through user signal events, such a DTMF digits, in-band as well as out-of-band telephony events (RFC 2833/4733) because they are not handled well in such systems. In accordance with the invention, a signalling event in incoming audio packets or user signalling event received out-of-band is detected at one of the inputs. A meta-data representation of the signal event is attached to the audio and passed through the mixer for regeneration, as in-band or out-of-band telephony events, on the other side of the mixer.

Abstract: The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of central nervous system disorders.

Abstract: The present invention relates to therapeutic methods using pharmaceutical compositions comprising one or a combination of co-agonists at the N-methyl-D-aspartate receptor for the treatment of visual system disorders.

Abstract: The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of visual system disorders and the enhancement of the visual function.

Abstract: Methods, systems, apparatuses and program products are disclosed for communications such as may be used for debugging computers and similar electronic products at a level suitable for low level firmware. This may find application, for example, in environments after cache initialization around the time of memory bring up or motherboard device enumeration but including durability into and beyond software loading. GPIO (General Purpose input/output) connections may be used for communication that may, for some purposes, be regarded as half-duplex but without necessarily being anisochronous.

Abstract: Disclosed are methods of treating disorders of the eye by administering to a patient in need of such treatment a compound represented by the formula Wherein R1 and R2 are independently hydrogen, alkyl, substituted alkyl, cycloalkyl, alkynyl, substituted alkynyl, cyano, alkoxy, carboxamido, substituted carboxamido, and if R1 and R2 are alkyl, R1 and R2 may be joined with a bond or —(CH2)m— to produce a cycloalkyl, R3 and R4 are independently hydrogen, alkyl, hydroxyl, alkoxy, cyano, fluoro, and if R3 and R4 are alkyl, R3 and R4 may be joined with a bond or —(CH2)m— to produce a cycloalkyl, Q may be absent, hydrogen, alkyl, cycloalkyl, cycloalkenyl, alkoxy, substituted alkoxy, substituted thio, cyano, thionitrile, sulfonamide, substituted sulfonamide, substituted sulfonyl, aromatic, substituted aromatic, heteroaromatic, substituted heteroaromatic, or bicycloheteroaromatic, R5 is hydrogen, alkyl, cycloalkyl, or when R6 is also alkyl, together with R6 may form a heterocycloalkyl ring, R6 may be hydrogen, alky

Abstract: A heat sink having a very high heat transfer capability may be made from a plurality of unit elements. Each unit element includes a series of inlet tubes having a range of diameters and a series of outlet tubes also having a range of diameters. At least one inlet tube having a minimum inlet tube diameter may be in flow communication with at least one outlet tube having a minimum outlet tube diameter.

Abstract: Disclosed are a protein encoded by a gene having a nucleotide sequence represented by any of SEQ ID NOs: 1 to 65 or a fragment thereof, an antibody recognizing the protein or antigen-binding fragment thereof, and a polynucleotide having a sequence comprising at least 12 consecutive nucleotides of a nucleotide sequence represented by any of SEQ ID NOs: 1 to 65 or a nucleotide sequence complementary thereto. The gene and the protein of the invention is useful for diagnosing and treating cancer.

Abstract: Systems and methods are provided for a distributed conferencing service through an internet protocol (IP) network. A plurality of tributary mixers are configured communicate with a master mixer or a plurality of master mixers, at least one of which communicates through the IP network. Each tributary mixer is configured to join one or more respective participants to the distributed conference, generate a first mixed media stream by mixing a plurality of ingress media streams from the respective participants, and receive a second mixed media stream from the master mixer. The second mixed media stream includes media from at least one other participant joined to the distributed conference through another of the tributary mixers. Each tributary mixer also provides egress media streams to its respective participants based on a control signal from the master mixer.

Abstract: Methods, systems, apparatuses and program products are disclosed for communications such as may be used for debugging computers and similar electronic products at a level suitable for low level firmware. This may find application, for example, in environments after cache initialization around the time of memory bring up or motherboard device enumeration but including durability into and beyond software loading. GPIO (General Purpose input/output) connections may be used for communication that may, for some purposes, be regarded as half-duplex but without necessarily being anisochronous.

Abstract: Disclosed are a protein encoded by a gene having a nucleotide sequence represented by any of SEQ ID NOs: 1 to 65 or a fragment thereof, an antibody recognizing the protein or antigen-binding fragment thereof, and a polynucleotide having a sequence comprising at least 12 consecutive nucleotides of a nucleotide sequence represented by any of SEQ ID NOs: 1 to 65 or a nucleotide sequence complementary thereto. The gene and the protein of the invention is useful for diagnosing and treating cancer.

Abstract: Disclosed are a protein encoded by a gene having a nucleotide sequence represented by any of SEQ ID NOs: 1 to 65 or a fragment thereof, an antibody recognizing the protein or antigen-binding fragment thereof, and a polynucleotide having a sequence comprising at least 12 consecutive nucleotides of a nucleotide sequence represented by any of SEQ ID NOs: 1 to 65 or a nucleotide sequence complementary thereto. The gene and the protein of the invention is useful for diagnosing and treating cancer.

Abstract: Disclosed are a protein encoded by a gene having a nucleotide sequence represented by any of SEQ ID NOs: 1 to 65 or a fragment thereof, an antibody recognizing the protein or antigen-binding fragment thereof, and a polynucleotide having a sequence comprising at least 12 consecutive nucleotides of a nucleotide sequence represented by any of SEQ ID NOs: 1 to 65 or a nucleotide sequence complementary thereto. The gene and the protein of the invention is useful for diagnosing and treating cancer.